Deborah R. Surman
Papers
1
Total Citations
8
H-Index
1
About
Deborah R. Surman is a translational cancer researcher whose work focuses on precision therapy for esophageal cancers, particularly through the integration of metabolomics and functional profiling. Her major contributions include pioneering the use of metabolomic and BH3 profiling to assess tumor responses to neoadjuvant chemoradiotherapy (nCRT), offering novel methods to identify patients who may achieve a complete pathological response. This approach aims to refine treatment strategies and reduce unnecessary surgeries. Her most cited paper, "Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy" (2018, 8 citations), addresses a critical gap in predicting therapeutic outcomes for a disease that accounts for nearly 16,000 deaths annually. While her citation counts are modest, her work is notable for its potential clinical impact in a challenging field, where improving patient stratification could significantly alter survival and quality of life. Surman’s research exemplifies the shift toward personalized oncology, bridging molecular profiling with practical treatment decisions.
Research Focus
Key Achievements
Top Papers
- 1